Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934433Aexternal-prioritypatent/DE19934433A1/en
Application filed by Merck Patent GmbhfiledCriticalMerck Patent Gmbh
Publication of SI1198453T1publicationCriticalpatent/SI1198453T1/en
New N-(indolyl-carbonyl)-N'-ethyl-piperazine derivatives, are 5-HT-2A receptor antagonists useful e.g. for treating schizophrenia, depression, Parkinson's disease, Alzheimer's disease or anorexia